Double-Barrelled Heck Cyclizations
763
fractions (RF 0 5, 3 : 1 hexane/ether elution) gave the title
compound (14) (920 mg, 89%) as a white crystalline solid, m.p.
122–123 C (Found: C, 39 5; H, 2 1; Br, 27 6; I, 22 1; N, 2 3.
m, 3H; 4 88, t, J 6 9 Hz, 2H; 3 21, t, J 6 9 Hz, 2H. 13C
n.m.r. 155 3 (C), 151 2 (C), 135 6 (C), 135 3 (C), 133 8
(C), 130 7 (CH), 129 4 (CH), 128 3 (CH), 128 1 (CH), 127 5
(C), 127 4 (CH), 126 9 (CH), 125 7 (CH), 123 7 (CH), 123 3
(CH), 118 2 (C), 117 5 (C), 117 1 (CH), 42 3 (CH2), 29 3
(CH2) (three peaks obscured or overlapping). Mass spectrum
m/z 363 (100%) (M+ ).
C
19H14Br2INO2 requires C, 39 7; H, 2 5; Br, 27 8; I, 22 1; N,
2 4%). (KBr) 2949, 1716, 1517, 1468, 1438, 1411, 1374,
1326, 1232, 1216, 1191, 1055, 1028 cm
max
1
.
1H n.m.r. 7 65,
dd, J 7 8 and 1 8 Hz, 1H; 7 55, dd, J 7 8 and 1 8 Hz, 1H;
7 37, m, 2H; 7 28–7 04, m, 5H; 6 70, d, J 2 1 Hz, 1H; 4 55,
t, J 7 5 Hz, 2H; 3 20, t, J 7 5 Hz, 2H. 13C n.m.r. 157 0 (C),
147 8 (C), 136 9 (C), 134 5 (CH), 133 3 (CH), 132 7 (CH),
131 2 (CH), 128 6 (CH), 128 4 (CH), 127 6 (CH), 127 3 (CH),
126 7 (CH), 124 4 (C), 124 0 (CH), 122 0 (C), 116 6 (C),
59 6 (C), 49 0 (CH2), 38 0 (CH2). Mass spectrum m/z 577
(1%) 575 (2) 573 (1) (M+ ); 496 (10) 494 (11) [(M Br )+];
404 (98) 402 (100) [(M C6H4BrO )+].
2 0-Bromophenyl 1-Phenyl-5,6-dihydropyrrolo[2,1-a]-
isoquinoline-3-carboxylate (16) and Bromo{2 0-(1 00-phenyl-
5 00,6 00-dihydropyrrolo[2,1-a]isoquinolin-3 00-ylcarbonyloxy)-
phenyl}bis(triphenylphosphine)palladium (17)
Pd(OAc)2 (197 mg, 0 88 mmol) was added to
a solu-
tion of compound (4) (230 mg, 0 438 mmol), NaOAc (80 mg,
0 975 mmol) and PPh3 (460 mg, 1 75 mmol) in dimethylfor-
mamide (20 ml). The solution was evacuated (1 0 mmHg)
and back- lled with N2 (gas) three times to remove dissolved
oxygen and then heated under nitrogen at 110 C for 19 h. The
cooled reaction mixture was diluted with ethyl acetate (25 ml)
then washed with brine (2 20 ml) and water (1 20 ml). The
separated organic phase was then dried (MgSO4), ltered and
concentrated under reduced pressure onto silica (2 g). Subjec-
tion of the resulting material to ash chromatography (silica,
1 : 2 then 1 : 1 CH2Cl2/hexane followed by 4 : 1 CH2Cl2/ethyl
acetate elution) gave two fractions, A and B.
2-Bromophenyl 1-[2 0-(2 00-Bromophenyl)ethyl]-4-phenylpyrrole-
2-carboxylate (4)
Phenylzinc chloride [prepared by the addition of anhydrous
zinc chloride (540 mg, 3 96 mmol) to a solution of phenyllithium
(2 0 ml of a 1 8 M solution in cyclohexane/ether, 3 6 mmol)
in tetrahydrofuran (4 0 ml)] was added dropwise, over 2 min,
to a magnetically stirred solution of compound (14) (1 75
g, 3 04 mmol) and Pd(PPh3)2Cl2 (106 mg, 0 152 mmol) in
dimethylformamide (15 ml). Stirring was continued at 18 C for
1 h then the reaction mixture was transferred to a separatory
funnel, diluted with ethyl acetate (100 ml) and washed with
NH4Cl (100 ml of a saturated aqueous solution) then H2O
(2 100 ml). The separated organic phase was dried (MgSO4),
ltered and concentrated under reduced pressure to give a
light-yellow oil which was subjected to ash chromatography
(silica, 2 : 1 hexane/CH2Cl2 elution). Concentration of the
appropriate fractions (RF 0 5) gave the title compound (4)
(1 52 g, 95%) as a microcrystalline solid, m.p. 90–92 C (Found:
C, 57 1; H, 3 4; Br, 30 7; N, 2 5. C25H19Br2NO2 requires C,
Concentration of fraction A (RF 0 6, 2 : 1 CH2Cl2/hexane
elution) a orded compound (16) (34 mg, 17%) as o -white
crystalline masses, m.p. 130–131 C (Found: M+ , 443 0529.
C
25H1879BrNO2 requires M+ , 443 0521).
(KBr) 2950,
max
1
1710, 1471, 1439, 1418, 1240, 1212, 1176, 1046 cm
.
1H n.m.r.
7 57, dd, J 8 1 and 1 5 Hz, 1H; 7 45–7 05, m, 12H; 6 95,
br t, J 8 1 Hz, 1H; 4 57, t, J 6 3 Hz, 2H; 3 05, t, J 6 3 Hz,
2H. 13C n.m.r. 158 5 (C), 148 1 (C), 136 1 (C), 133 4 (C),
133 3 (CH), 132 9 (C), 129 1 (CH), 128 6 (C), 128 4 (CH),
128 1 (C), 127 9 (CH), 127 7 (CH), 127 1 (CH), 126 9 (CH),
126 7 (CH), 125 5 (CH), 124 2 (CH), 123 5 (C), 121 3 (CH),
119 4 (C), 116 7 (C), 42 4 (CH2), 29 5 (CH2). Mass spectrum
m/z 445 (10%) 443 (9) (M+ ); 272 (100) [(M C6H4BrO )+].
57 2; H, 3 7; Br, 30 4; N, 2 7%). max (KBr) 2958, 2930, 1718,
1
1603, 1580, 1562, 1472, 1397, 1215, 1196, 1066, 1024 cm
.
1H n.m.r. 7 70, dd, J 8 0 and 1 5 Hz, 1H; 7 60–7 00, m,
14H; 4 63, t, J 6 9 Hz, 2H; 3 32, t, J 6 9 Hz, 2H. 13C n.m.r.
(75 5 MHz, CDCl3) 158 4 (C), 148 3 (C), 137 5 (C), 134 2
(C), 133 5 (CH), 132 9 (C), 131 5 (CH), 128 9 (CH), 128 6(3)
(CH), 128 6(1) (CH), 127 8 (CH), 127 4 (CH), 127 3 (CH),
126 5 (CH), 125 4 (CH), 124 8 (C), 124 6 (C), 124 4 (CH),
120 9 (C), 117 5 (CH), 116 9 (C), 49 3 (CH2), 38 2 (CH2).
Mass spectrum m/z 527 (3%) 525 (6) 523 (3) (M+ ); 446 (12)
444 (11) [(M Br )+]; 354 (100) 352 (96) [(M C6H4BrO )+].
Concentration of fraction
a orded compound (17) (40 mg, 8 5%) as o -white crystalline
masses, m.p. 159–162 C. (KBr) 3052, 2923, 1705, 1481,
1435, 1416, 1238, 1172, 1095, 1058, 1024 cm
B (RF 0 1, CH2Cl2 elution)
max
1
.
1H n.m.r.
7 65–7 40, m, 18H; 7 30–7 05, m, 22H; 6 58, m, 1H; 6 52, t,
J 6 6 Hz, 1H; 6 39, m, 1H; 6 07, q, J 6 6 Hz, 1H; 4 73, m,
2H; 3 05, m, 2H. 13C n.m.r. 159 2 (C), 151 8 (C), 138 3
(CH), 136 5 (C), 134 8 (CH), 133 2 (C), 131 8 (C), 131 5
(C), 131 0 (C), 129 9 (CH), 129 8 (CH), 129 5 (CH), 129 0
(CH), 128 7 (C), 127 8 (CH), 127 5 (CH), 127 2 (CH), 127 0
(CH), 125 7 (CH), 125 0 (CH), 123 2 (C), 123 0 (CH), 121 9
(CH), 121 1 (C), 120 5 (CH), 42 2 (CH2), 29 7 (CH2). Mass
spectrum m/z 365 (6%) [(M Pd(PPh3)2Br+H)+ ]; 277 (26);
272 (32) {[M C6H4OPd(PPh3)2Br]+}; 262 (100) (Ph3P+ ).
14-Phenyl-8,9-dihydro-6 H-[1]benzopyrano[4 0,3 0:4,5]pyrrolo-
[2,1-a]isoquinolin-6-one (3)
Pd(OAc)2 (32 mg, 0 143 mmol) was added to a magnetically
stirred solution of compound (4) (148 mg, 0 282 mmol), NaOAc
(92 7 mg, 1 13 mmol) and PPh3 (74 0 mg, 0 282 mmol) in
dimethylformamide (2 ml) contained in a Schlenk tube. The
resulting mixture was evacuated (1 0 mmHg) and back- lled
with N2 (gas) three times (to remove dissolved oxygen) then
heated under nitrogen at 135 C for 6 h. The cooled reaction
mixture was diluted with ether (25 ml) and washed with brine
(2 20 ml) then water (20 ml) before being dried (MgSO4),
ltered and concentrated onto silica (2 g). The residue was
subjected to ash chromatography (silica, 1 : 2, 1 : 1 then 2 : 1
CH2Cl2/hexane elution) and the appropriate fractions (RF 0 3,
2 : 1 CH2Cl2/hexane elution) were concentrated under reduced
pressure to give the title compound (3) (16 mg, 16%) as
1-Phenyl-5,6-dihydropyrrolo[2,1-a]isoquinoline (18) and 1-
[2 0-(2 00-Bromophenyl)ethyl]-3-phenylpyrrole (19)
A
solution of the dibromide (4) (13 mg, 25 mol),
trans-di( -acetato)bis[o -(di-o -tolylphosphino)benzyl]dipalla-
dium(II)16 (2 5 mg, 2 5 mol) and anhydrous sodium acetate
(6 2 mg, 75 mol) in degassed N,N -dimethylacetamide (0 25
ml) was heated, under nitrogen, at 140 C for 72 h. The cooled
reaction mixture was then diluted with diethyl ether (5 ml)
and the resulting solution washed with brine/water (3 5 ml
of a 1 : 1 v/v mixture). The organic phase was then dried
(MgSO4), ltered and concentrated under reduced pressure to
give a light-yellow oil. Subjection of this material to ash
chromatography (silica, 3 : 7 then 7 : 3 CH2Cl2/hexane elution)
gave, after concentration of the appropriate fractions (RF 0 7,
3 : 7 CH2Cl2/hexane elution), a 1 : 3 mixture of compounds
(18) and (19) (4 mg, 52% combined yield) as a light-yellow
cream-coloured microcrystals, m.p. 259–260 C (Found: M+
363 1257. C25H17NO2 requires M+ , 363 1259).
(KBr)
2925, 2853, 1708, 1449, 1420, 1396, 1339, 1281, 1241, 1198,
,
max
1
1151, 1133, 1106, 1085, 1047 cm
.
1H n.m.r.
7 58–7 55,
m, 2H; 7 51–7 50, m, 2H; 7 40, dd, J 7 5 and 0 9 Hz, 1H;
7 32–7 18, m, 4H; 7 10, dd, J 7 8 and 1 2 Hz, 1H; 7 01–6 97,